Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018). Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science, 361(6408), eaau1184. PMID: 30237320 PMCID: PMC8025225 DOI: 10.1126/science.aau1184. URL
Jutkowitz, Eric, Fernando Alarid-Escudero, Karen M. Kuntz, and Hawre Jalal. "The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis." PharmacoEconomics 37, no. 7 (2019): 871-877. doi: 10.1007/s40273-019-00770-z. URL
Alarid-Escudero, Fernando, Eva A. Enns, Karen M. Kuntz, Tzeyu L. Michaud, and Hawre Jalal. “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier." Value in Health 22, no. 5 (2019): 611-618. PMID: 31104743 PMCID: PMC6530578 DOI: 10.1016/j.jval.2019.02.008. URL
Jalal, H., & Alarid-Escudero, F. (2018). A Gaussian approximation approach for value of information analysis. Medical Decision Making, 38(2), 174-188. PMID: 28735563 DOI: 10.1177/0272989X17715627. URL
Jutkowitz E, Alarid-Escudero F, Choi H, Kuntz K, Jalal H. Value of information analyses of gout therapies: Using a meta-modeling approach. PharmacoEconomics. In Press (2017). URL
Jalal, H., Pechlivanoglou, P., Krijkamp, E., Alarid-Escudero, F., Enns, E., & Hunink, M. M. (2017). An Overview of R in Health Decision Sciences. Medical Decision Making. PMID: 28061043 DOI: 10.1177/0272989X16686559. URL
Chen, B. K., Jalal, H., Hashimoto, H., Suen, S. C., Eggleston, K., Hurley, M., Bhattacharya, J. Forecasting Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan. The Journal of the Economics of Ageing. 2016. Accepted, and National Bureau of Economic Research (No. w21870). PMID: 28580275 PMCID: PMC5451156 DOI: 10.1016/j.jeoa.2016.06.001. URL
Jalal, H., O'Dell, J. R., Bridges, S. L., Cofield, S., Curtis, J. R., Mikuls, T. R., Moreland, L. W., Michaud, K. Cost-Effectiveness of Triple Therapy versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis. Arthritis care & research. 2016. PMID: 27015606 DOI: 10.1002/acr.22895. URL
Michaud, T. L., Abraham, J., Jalal, H. J., Luepker, R. V., Duval, S., & Hirsch, A. T.. Cost-effectiveness of a statewide campaign to promote aspirin use for primary prevention of cardiovascular disease. Journal of the American Heart Association. 2015. 4(12), e002321. PMID: 26702086 PMCID: PMC4845274 DOI: 10.1161/JAHA.115.002321. URL
Goldhaber-Fiebert J, Jalal H. Some health states are certainly better than others: Using health state rank order to improve probabilistic sensitivity analyses. Medical Decision Making. 2015. 0272989X15605091. PMID: 26377369 PMCID: PMC4794424 DOI: 10.1177/0272989X15605091. URL
Jalal H, Goldhaber-Fiebert J, Kuntz KM. Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling, Medical Decision Making (Online 2015). DOI: 10.1177/0272989X15578125. URL
Leung TI, Jalal HJ, Zulman DM, Dumontier M, Owens DK, Musen MA, Goldstein MK. “Automating Identification of Multiple Chronic Conditions in Clinical Practice Guideline Recommendations.” JAMIA Proceedings, 2015. PMID: 26306285 PMCID: PMC4525235. URL
Jalal H, Dowd B, Sainfort F, Kuntz KM. Linear regression metamodeling as a tool to summarize and present simulation model results. Med Decis Making 2013;7:880-890. PMID: 23811758 PMCID: PMC8008505 DOI: 10.1177/0272989X13492014. URL
Wang SY, Chu H, Shamliyan T, Jalal H, Kuntz KM, Kane R, Virnig B. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst. 2012;104:507–516. PMID: 22440677 PMCID: PMC3916966 DOI: 10.1093/jnci/djs142. URL
Nyman J, Jalal H. Including indirect medical care costs from survivor years of life in economic evaluations. PharmacoEconomics. 2011;29:173-174. PMID: 21309614 DOI: 10.2165/11588790-000000000-00000. URL